Literature DB >> 10563426

Primary central nervous system lymphoma: from clinical presentation to diagnosis.

U Herrlinger1, M Schabet, M Bitzer, D Petersen, P Krauseneck.   

Abstract

Immunocompetent patients with primary central nervous system lymphoma (PCNSL) present with a median age of 55 years, immunosuppressed patients with a median age of 40 years. They show a broad range of signs and symptoms. Symptoms of increased intracranial pressure and personality change are most frequent, followed in frequency by ataxia and hemiparesis. The median time from onset of symptoms to diagnosis is 3-5 months in immunocompetent patients and 2 months in immunodeficient patients. The time to diagnosis can be considerably longer in patients with slowly developing personality change or fluctuating symptoms due to spontaneous or steroid-induced remission of so-called sentinel lesions. Native CT scans show iso- or hyperdense lesions with homogenous contrast enhancement. T1-weighted MRI scans show hypointense and T2-weighted scans hyperintense lesions. The definitive diagnosis of PCNSL requires biopsy. In some cases, however, the definitive diagnosis may exclusively be made by the demonstration of malignant B-lymphocytes in the cerebrospinal fluid.

Entities:  

Mesh:

Year:  1999        PMID: 10563426     DOI: 10.1023/a:1006298201101

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  55 in total

1.  AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors.

Authors:  S Camilleri-Broët; F Davi; J Feuillard; D Seilhean; J F Michiels; P Brousset; B Epardeau; E Navratil; K Mokhtari; C Bourgeois; L Marelle; M Raphäel; J J Hauw
Journal:  Hum Pathol       Date:  1997-03       Impact factor: 3.466

Review 2.  Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study.

Authors:  D F Braus; K Schwechheimer; H K Müller-Hermelink; G Schwarzkopf; B Volk; F Mundinger
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

3.  Diabetes insipidus as first manifestation of primary central nervous system lymphoma.

Authors:  C M Balmaceda; M R Fetell; J E Selman; A J Seplowitz
Journal:  Neurology       Date:  1994-02       Impact factor: 9.910

4.  Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma.

Authors:  U Herrlinger; M Schabet; M Clemens; R D Kortmann; D Petersen; B E Will; R Meyermann; J Dichgans
Journal:  Acta Neurol Scand       Date:  1998-04       Impact factor: 3.209

5.  Primary intracranial CNS lymphoma: MR manifestations.

Authors:  B W Schwaighofer; J R Hesselink; G A Press; R L Wolf; M E Healy; D P Berthoty
Journal:  AJNR Am J Neuroradiol       Date:  1989 Jul-Aug       Impact factor: 3.825

6.  Primary malignant lymphomas of the central nervous system.

Authors:  J M Henry; R R Heffner; S H Dillard; K M Earle; R L Davis
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

7.  Epidemiology of primary CNS lymphoma.

Authors:  M Schabet
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

8.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Combined modality therapy for primary CNS lymphoma.

Authors:  L M DeAngelis; J Yahalom; H T Thaler; U Kher
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

10.  Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford.

Authors:  T L Helle; R H Britt; T V Colby
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

View more
  16 in total

Review 1.  Diagnosis and treatment of primary central nervous system lymphoma.

Authors:  Igor T Gavrilovic; Lauren E Abrey
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

2.  A 60-year-old Indian male with altered sensorium and extensive lymphoma of the scalp.

Authors:  Budhi S Yadav; Anshuma Bansal; Suresh C Sharma; Pankaj Malhotra; Nilanjan Ghosh; Matthias Holdhoff; Andrei Shustov; Marc Chamberlain; Herbert Newton; Priya Kumethkar; Jeffrey N Raizer; Jon Glass; Gloria J Morris
Journal:  Semin Oncol       Date:  2013-06       Impact factor: 4.929

3.  Immunophenotyping of Tumours.

Authors:  R Lakhtakia; S K Nema
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Primary Central Nervous System Lymphoma.

Authors:  Denise M. Damek
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

5.  MRI findings of primary CNS lymphoma in 26 immunocompetent patients.

Authors:  Dong Zhang; Liang-Bo Hu; Tobias D Henning; Elisabeth M Ravarani; Li-Guang Zou; Xiao-Yuan Feng; Wen-Xian Wang; Li Wen
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

Review 6.  Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features.

Authors:  Sarah E Coupland; Heinrich Heimann; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-29       Impact factor: 3.117

7.  Primary central nervous system lymphoma.

Authors:  Stephane Doucet; Priya Kumthekar; Jeffrey Raizer
Journal:  Curr Treat Options Oncol       Date:  2013-06

Review 8.  Primary central nervous system lymphoma.

Authors:  Igor T Gavrilovic; Lauren E Abrey
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

9.  Molecular pathology of primary intraocular lymphoma.

Authors:  Chi-Chao Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 10.  Intraocular lymphoma: update on diagnosis and management.

Authors:  Chi-Chao Chan; Dana J Wallace
Journal:  Cancer Control       Date:  2004 Sep-Oct       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.